Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2007-04-17
2007-04-17
Campell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C435S007100, C435S975000, C424S093100
Reexamination Certificate
active
10089292
ABSTRACT:
A highly immunoreactive viral peptide, pE2, is disclosed which is derived from the carboxy-terminal end region of ORF2 region of the hepatitis E virus (HEV) genome. A unique feature of the novel pE2 peptide is that it possesses conformational antigenic determinants which are only exposed when monomers of the peptide associate with one another through non-covalent interactions to naturally form homodimers. The novel pE2 peptide is proven to be highly reactive with sera from patients having current or past infection with HEV which suggests that the homodimer may mimic certain structural features of the HEV capsid protein. Furthermore, the antigenic activity of the pE2 peptide is strictly conformational in nature and therefore, exhibits immunochemical reactivity only when the peptide exists in a dimeric form. Consequently, the antigenic activity is lost upon dissociation of the dimers, but the activity is restored when the monomers reassociate to form dimers. Moreover, diagnostic methods useful in detecting and diagnosing HEV infection, and the use of a vaccine composition effective in preventing hepatitis E virus infection in which the novel pE2 peptide is utilized are also disclosed.
REFERENCES:
patent: 5686239 (1997-11-01), Reyes et al.
patent: 5741490 (1998-04-01), Reyes et al.
patent: 6514690 (2003-02-01), Li et al.
Khudyakov et al. Virol. 1994, pp. 390-393.
Catalog of amersham pharmacia biotech 1998, pp. 86.
Im Stanley
Ng Hon Mun
Zhang Jizhong
Campell Bruce R.
Li Bao Qun
Yang Sheng Tang Company Limited
LandOfFree
HEV antigenic peptide and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HEV antigenic peptide and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HEV antigenic peptide and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3789744